Logo image of NYT

NEW YORK TIMES CO-A (NYT) Stock Fundamental Analysis

NYSE:NYT - US6501111073 - Common Stock

59.83 USD
+0.09 (+0.15%)
Last: 8/29/2025, 10:00:56 AM
Fundamental Rating

7

Taking everything into account, NYT scores 7 out of 10 in our fundamental rating. NYT was compared to 100 industry peers in the Media industry. Both the health and profitability get an excellent rating, making NYT a very profitable company, without any liquidiy or solvency issues. NYT is not valued too expensively and it also shows a decent growth rate. These ratings could make NYT a good candidate for quality investing.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

NYT had positive earnings in the past year.
In the past year NYT had a positive cash flow from operations.
Each year in the past 5 years NYT has been profitable.
NYT had a positive operating cash flow in each of the past 5 years.
NYT Yearly Net Income VS EBIT VS OCF VS FCFNYT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

1.2 Ratios

With an excellent Return On Assets value of 11.42%, NYT belongs to the best of the industry, outperforming 95.00% of the companies in the same industry.
NYT has a Return On Equity of 16.55%. This is amongst the best in the industry. NYT outperforms 86.00% of its industry peers.
Looking at the Return On Invested Capital, with a value of 14.36%, NYT belongs to the top of the industry, outperforming 96.00% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for NYT is above the industry average of 7.52%.
The 3 year average ROIC (11.43%) for NYT is below the current ROIC(14.36%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROIC 14.36%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
NYT Yearly ROA, ROE, ROICNYT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 11.92%, NYT belongs to the top of the industry, outperforming 85.00% of the companies in the same industry.
NYT's Profit Margin has improved in the last couple of years.
NYT's Operating Margin of 15.50% is amongst the best of the industry. NYT outperforms 83.00% of its industry peers.
NYT's Operating Margin has improved in the last couple of years.
NYT's Gross Margin of 50.04% is in line compared to the rest of the industry. NYT outperforms 60.00% of its industry peers.
In the last couple of years the Gross Margin of NYT has declined.
Industry RankSector Rank
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
NYT Yearly Profit, Operating, Gross MarginsNYT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so NYT is still creating some value.
The number of shares outstanding for NYT has been reduced compared to 1 year ago.
The number of shares outstanding for NYT has been reduced compared to 5 years ago.
There is no outstanding debt for NYT. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NYT Yearly Shares OutstandingNYT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
NYT Yearly Total Debt VS Total AssetsNYT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

NYT has an Altman-Z score of 9.48. This indicates that NYT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 9.48, NYT belongs to the top of the industry, outperforming 91.00% of the companies in the same industry.
NYT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 9.48
ROIC/WACC1.62
WACC8.88%
NYT Yearly LT Debt VS Equity VS FCFNYT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

NYT has a Current Ratio of 1.48. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
The Current ratio of NYT (1.48) is comparable to the rest of the industry.
NYT has a Quick Ratio of 1.48. This is a normal value and indicates that NYT is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of NYT (1.48) is comparable to the rest of the industry.
The current and quick ratio evaluation for NYT is rather negative, while it does have excellent solvency and profitability. These ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
Industry RankSector Rank
Current Ratio 1.48
Quick Ratio 1.48
NYT Yearly Current Assets VS Current LiabilitesNYT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

5

3. Growth

3.1 Past

NYT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 22.40%, which is quite impressive.
NYT shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.92% yearly.
The Revenue has been growing slightly by 7.82% in the past year.
Measured over the past years, NYT shows a small growth in Revenue. The Revenue has been growing by 7.37% on average per year.
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%

3.2 Future

The Earnings Per Share is expected to grow by 13.13% on average over the next years. This is quite good.
Based on estimates for the next years, NYT will show a small growth in Revenue. The Revenue will grow by 6.49% on average per year.
EPS Next Y16.88%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
EPS Next 5Y13.13%
Revenue Next Year7.7%
Revenue Next 2Y7.1%
Revenue Next 3Y6.42%
Revenue Next 5Y6.49%

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
NYT Yearly Revenue VS EstimatesNYT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
NYT Yearly EPS VS EstimatesNYT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 26.71, which means the current valuation is very expensive for NYT.
Compared to the rest of the industry, the Price/Earnings ratio of NYT indicates a somewhat cheap valuation: NYT is cheaper than 67.00% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.17, NYT is valued at the same level.
NYT is valuated rather expensively with a Price/Forward Earnings ratio of 23.48.
Compared to the rest of the industry, the Price/Forward Earnings ratio of NYT is on the same level as its industry peers.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.78, NYT is valued at the same level.
Industry RankSector Rank
PE 26.71
Fwd PE 23.48
NYT Price Earnings VS Forward Price EarningsNYT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NYT is on the same level as its industry peers.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of NYT indicates a somewhat cheap valuation: NYT is cheaper than 62.00% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 21.4
EV/EBITDA 17.65
NYT Per share dataNYT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
NYT has an outstanding profitability rating, which may justify a higher PE ratio.
NYT's earnings are expected to grow with 12.09% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.58
PEG (5Y)1.58
EPS Next 2Y12.58%
EPS Next 3Y12.09%

6

5. Dividend

5.1 Amount

NYT has a Yearly Dividend Yield of 1.21%. Purely for dividend investing, there may be better candidates out there.
NYT's Dividend Yield is a higher than the industry average which is at 4.93.
With a Dividend Yield of 1.21, NYT pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 1.21%

5.2 History

On average, the dividend of NYT grows each year by 21.48%, which is quite nice.
NYT has been paying a dividend for at least 10 years, so it has a reliable track record.
NYT has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)21.48%
Div Incr Years6
Div Non Decr Years11
NYT Yearly Dividends per shareNYT Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

NYT pays out 29.50% of its income as dividend. This is a sustainable payout ratio.
NYT's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP29.5%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
NYT Yearly Income VS Free CF VS DividendNYT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
NYT Dividend Payout.NYT Dividend Payout, showing the Payout Ratio.NYT Dividend Payout.PayoutRetained Earnings

NEW YORK TIMES CO-A

NYSE:NYT (8/29/2025, 10:00:56 AM)

59.83

+0.09 (+0.15%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)08-06 2025-08-06/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners97.12%
Inst Owner Change-0.23%
Ins Owners0.62%
Ins Owner Change0.95%
Market Cap9.74B
Analysts75
Price Target60.85 (1.7%)
Short Float %7.02%
Short Ratio5.94
Dividend
Industry RankSector Rank
Dividend Yield 1.21%
Yearly Dividend0.5
Dividend Growth(5Y)21.48%
DP29.5%
Div Incr Years6
Div Non Decr Years11
Ex-Date07-09 2025-07-09 (0.18)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)16.94%
Min EPS beat(2)15.73%
Max EPS beat(2)18.14%
EPS beat(4)4
Avg EPS beat(4)12.21%
Min EPS beat(4)6.49%
Max EPS beat(4)18.14%
EPS beat(8)8
Avg EPS beat(8)19.88%
EPS beat(12)12
Avg EPS beat(12)28.39%
EPS beat(16)16
Avg EPS beat(16)25.56%
Revenue beat(2)1
Avg Revenue beat(2)0.21%
Min Revenue beat(2)-0.82%
Max Revenue beat(2)1.24%
Revenue beat(4)1
Avg Revenue beat(4)-0.41%
Min Revenue beat(4)-1.09%
Max Revenue beat(4)1.24%
Revenue beat(8)2
Avg Revenue beat(8)-0.53%
Revenue beat(12)4
Avg Revenue beat(12)-0.43%
Revenue beat(16)6
Avg Revenue beat(16)-0.34%
PT rev (1m)6.55%
PT rev (3m)9.65%
EPS NQ rev (1m)7.57%
EPS NQ rev (3m)11.99%
EPS NY rev (1m)5.89%
EPS NY rev (3m)6.02%
Revenue NQ rev (1m)0.32%
Revenue NQ rev (3m)0.87%
Revenue NY rev (1m)0.93%
Revenue NY rev (3m)1.11%
Valuation
Industry RankSector Rank
PE 26.71
Fwd PE 23.48
P/S 3.62
P/FCF 21.4
P/OCF 19.88
P/B 5.03
P/tB 7.59
EV/EBITDA 17.65
EPS(TTM)2.24
EY3.74%
EPS(NY)2.55
Fwd EY4.26%
FCF(TTM)2.8
FCFY4.67%
OCF(TTM)3.01
OCFY5.03%
SpS16.51
BVpS11.89
TBVpS7.88
PEG (NY)1.58
PEG (5Y)1.58
Profitability
Industry RankSector Rank
ROA 11.42%
ROE 16.55%
ROCE 18.71%
ROIC 14.36%
ROICexc 18.96%
ROICexgc 30.93%
OM 15.5%
PM (TTM) 11.92%
GM 50.04%
FCFM 16.93%
ROA(3y)8.59%
ROA(5y)7.74%
ROE(3y)13.1%
ROE(5y)12.23%
ROIC(3y)11.43%
ROIC(5y)10.49%
ROICexc(3y)14.65%
ROICexc(5y)14.2%
ROICexgc(3y)25.48%
ROICexgc(5y)21.57%
ROCE(3y)14.89%
ROCE(5y)13.67%
ROICexcg growth 3Y17%
ROICexcg growth 5Y17.39%
ROICexc growth 3Y3.36%
ROICexc growth 5Y8.52%
OM growth 3Y3.09%
OM growth 5Y7.54%
PM growth 3Y2.34%
PM growth 5Y8.02%
GM growth 3Y-0.36%
GM growth 5Y-4.15%
F-Score9
Asset Turnover0.96
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr 41.07%
Cap/Sales 1.29%
Interest Coverage 250
Cash Conversion 97.77%
Profit Quality 142.1%
Current Ratio 1.48
Quick Ratio 1.48
Altman-Z 9.48
F-Score9
WACC8.88%
ROIC/WACC1.62
Cap/Depr(3y)35.41%
Cap/Depr(5y)44.4%
Cap/Sales(3y)1.22%
Cap/Sales(5y)1.45%
Profit Quality(3y)113.54%
Profit Quality(5y)142.07%
High Growth Momentum
Growth
EPS 1Y (TTM)22.4%
EPS 3Y16.23%
EPS 5Y16.92%
EPS Q2Q%28.89%
EPS Next Y16.88%
EPS Next 2Y12.58%
EPS Next 3Y12.09%
EPS Next 5Y13.13%
Revenue 1Y (TTM)7.82%
Revenue growth 3Y7.62%
Revenue growth 5Y7.37%
Sales Q2Q%9.72%
Revenue Next Year7.7%
Revenue Next 2Y7.1%
Revenue Next 3Y6.42%
Revenue Next 5Y6.49%
EBIT growth 1Y22.62%
EBIT growth 3Y10.95%
EBIT growth 5Y15.46%
EBIT Next Year31.33%
EBIT Next 3Y16.76%
EBIT Next 5YN/A
FCF growth 1Y101.81%
FCF growth 3Y17.6%
FCF growth 5Y21.42%
OCF growth 1Y92.64%
OCF growth 3Y15.12%
OCF growth 5Y16.67%